Phosphoric Acid

Phosphoric Acid

SCHEMBL1292575

O.O.O.O.O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P([O-])(O)O.O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.61
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
TYMS P04818 1/20 0.33
CA2 P00918 1/20 0.33
FDPS P14324 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL7163381 0.96 SLC34A1 (0.67) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL39459 0.96 SLC34A1 (0.67) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL18887598 0.96 SLC34A1 (0.67) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL8508247 0.96 SLC34A1 (0.67) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL27038916 0.91 SLC34A1 (0.73) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL19086896 0.91 SLC34A1 (0.73) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL298141 0.91 SLC34A1 (0.73) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL193060 0.91 SLC34A1 (0.73) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL210340 0.91 SLC34A1 (0.73) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL19086897 0.91 SLC34A1 (0.73) SLC34A1LMNAKDM4ECYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115872380-B Octahedral calcium phosphate nanoflower and preparation method thereof 中国机械总院集团武汉材料保护研究所有限公司 2025-05-02 CN claimed
CN-115872380-A Octahcalcium phosphate pentahydrate nanoflower and preparation method thereof 武汉材料保护研究所有限公司 2023-03-31 CN claimed
CN-110545784-B Oral care compositions 联合利华知识产权控股有限公司 2022-10-25 CN claimed
EP-2902006-B1 CURABLE COMPOSITION FOR DENTISTRY, AND METHOD FOR PRODUCING SAME KURARAY NORITAKE DENTAL INC (JP) 2021-03-10 EP claimed
US-10603250-B2 One-pack type dentinal tubule occlusion material KURARAY NORITAKE DENTAL INC. (JP) 2020-03-31 US claimed
EP-2626058-B1 DENTINAL TUBULE SEALANT AND METHOD FOR PRODUCING THE SAME KURARAY NORITAKE DENTAL INC (JP) 2019-05-01 EP claimed
US-10029028-B2 Biomimetic collagen-hydroxyapatite composite material GEISTLICH PHARMA AG (CH) 2018-07-24 US claimed
EP-3021883-B1 BIOMIMETIC COLLAGEN-HYDROXYAPATITE COMPOSITE MATERIAL GEISTLICH PHARMA AG (CH) 2016-11-09 EP claimed
US-9427381-B2 Dental curable composition, and method for producing same KURARAY NORITAKE DENTAL INC. (JP) 2016-08-30 US claimed
US-20160144071-A1 BIOMIMETIC COLLAGEN-HYDROXYAPATITE COMPOSITE MATERIAL GEISTLICH PHARMA AG (CH) 2016-05-26 US claimed
US-20150209251-A1 DENTINAL TUBULE SEALANT AND METHOD FOR PRODUCING THE SAME KURARAY NORITAKE DENTAL INC. (JP) 2015-07-30 US claimed
US-20150202123-A1 DENTAL CURABLE COMPOSITION, AND METHOD FOR PRODUCING SAME KURARAY NORITAKE DENTAL INC. (JP) 2015-07-23 US claimed
WO-2015007393-A1 BIOMIMETIC COLLAGEN-HYDROXYAPATITE COMPOSITE MATERIAL GEISTLICH PHARMA AG (CH) 2015-01-22 WO claimed
EP-2826495-A1 Biomimetic collagen-hydroxyapatite composite material Geistlich Pharma AG (CH) 2015-01-21 EP claimed
EP-2626058-A1 DENTAL CANALICULI SEALING AGENT AND METHOD FOR PRODUCING THE SAME KURARAY NORITAKE DENTAL INC. (JP) 2013-08-14 EP claimed
US-20130189337-A1 DENTINAL TUBULE SEALANT AND METHOD FOR PRODUCING THE SAME KURARAY NORITAKE DENTAL INC. (JP) 2013-07-25 US claimed
US-20070098617-A1 Calcium phosphate bone replacement materials and methods of use thereof LAGOW RICHARD J 2007-05-03 US claimed
US-7045105-B2 Calcium phosphate bone replacement materials and methods of use thereof LAGOW RICHARD J 2006-05-16 US claimed
US-20040022825-A1 Calcium phosphate bone replacement materials and methods of use thereof LAGOW RICHARD J (US) 2004-02-05 US claimed
WO-2003055418-A1 CALCIUM PHOSPHATE BONE REPLACEMENT MATERIALS AND METHODS OF USE THEREOF LAGOW RICHARD J (US) 2003-07-10 WO claimed